Current Price Status
Stock is in Momentum
Stock is currently overvalued by the market with the expectation of annual earning growth at 108.03% to match current price.
Overvalued stock can be traded very volatile. If the earning growth momentum continue, overvalued stock can match into fair value, on the flip side, the downside risk can be huge if the stock is not meeting the market expectation.
Company is not in Profit
- IHH current price is 8.11% above OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Potential Better Revenue Growth
IHH posted a better revenue growth than average in the recent quarter.
Continued Losing Money
IHH has been losing money in the 2 of the past 5 quarters.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
IHH recent daily traded volume is -11.76% lower than past month average.
|Past 30-Day||Past 5-Day|
|17k daily||15k daily|
Price History Chart
Past 30-day Average Price: RM5.58
Stock Thematic Baskets
Market News & Investor Opinions
Stock Company Profile
IHH HEALTHCARE BERHAD
IHH Healthcare Bhd. operates as an investment holding company. The firm engages in the provision of healthcare services. It operates through the following geographical segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health and PLife REIT. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.